Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
2019 Jul 30;11631:15706-15715. doi: 10.1073/pnas.1822076116.
Show Gene links
Show Anatomy links
A newly developed anesthetic based on a unique chemical core.
Cayla NS
,
Dagne BA
,
Wu Y
,
Lu Y
,
Rodriguez L
,
Davies DL
,
Gross ER
,
Heifets BD
,
Davies MF
,
MacIver MB
,
Bertaccini EJ
.
???displayArticle.abstract???
Intravenous anesthetic agents are associated with cardiovascular instability and poorly tolerated in patients with cardiovascular disease, trauma, or acute systemic illness. We hypothesized that a new class of intravenous (IV) anesthetic molecules that is highly selective for the slow type of γ-aminobutyric acid type A receptor (GABAAR) could have potent anesthetic efficacy with limited cardiovascular effects. Through in silico screening using our GABAAR model, we identified a class of lead compounds that are N-arylpyrrole derivatives. Electrophysiological analyses using both an in vitro expression system and intact rodent hippocampal brain slice recordings demonstrate a GABAAR-mediated mechanism. In vivo experiments also demonstrate overt anesthetic activity in both tadpoles and rats with a potency slightly greater than that of propofol. Unlike the clinically approved GABAergic anesthetic etomidate, the chemical structure of our N-arylpyrrole derivative is devoid of the chemical moieties producing adrenal suppression. Our class of compounds also shows minimal to no suppression of blood pressure, in marked contrast to the hemodynamic effects of propofol. These compounds are derived from chemical structures not previously associated with anesthesia and demonstrate that selective targeting of GABAAR-slow subtypes may eliminate the hemodynamic side effects associated with conventional IV anesthetics.
Altschul,
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
1997, Pubmed
Altschul,
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
1997,
Pubmed
Asproni,
Synthesis, structure-activity relationships at the GABA(A) receptor in rat brain, and differential electrophysiological profile at the recombinant human GABA(A) receptor of a series of substituted 1,2-diphenylimidazoles.
2005,
Pubmed
,
Xenbase
Berman,
The Protein Data Bank.
2000,
Pubmed
Bertaccini,
Normal-mode analysis of the glycine alpha1 receptor by three separate methods.
2007,
Pubmed
Bertaccini,
Assessment of homology templates and an anesthetic binding site within the γ-aminobutyric acid receptor.
2013,
Pubmed
Bieda,
Anesthetics discriminate between tonic and phasic gamma-aminobutyric acid receptors on hippocampal CA1 neurons.
2009,
Pubmed
Bonin,
Alpha5GABAA receptors regulate the intrinsic excitability of mouse hippocampal pyramidal neurons.
2007,
Pubmed
Braberg,
SALIGN: a web server for alignment of multiple protein sequences and structures.
2012,
Pubmed
Brooks,
CHARMM: the biomolecular simulation program.
2009,
Pubmed
Cotten,
Carboetomidate: a pyrrole analog of etomidate designed not to suppress adrenocortical function.
2010,
Pubmed
,
Xenbase
Dagne,
High Dose Gamma Radiation Selectively Reduces GABAA-slow Inhibition.
2017,
Pubmed
Eswar,
Protein structure modeling with MODELLER.
2008,
Pubmed
Fahrenbach,
Insights Into Receptor-Based Anesthetic Pharmacophores and Anesthetic-Protein Interactions.
2018,
Pubmed
Forman,
Molecular approaches to improving general anesthetics.
2010,
Pubmed
Forman,
Clinical and molecular pharmacology of etomidate.
2011,
Pubmed
Gredell,
Determination of diffusion and partition coefficients of propofol in rat brain tissue: implications for studies of drug action in vitro.
2004,
Pubmed
Higgins,
Using CLUSTAL for multiple sequence alignments.
1996,
Pubmed
Hoerbelt,
Native System and Cultured Cell Electrophysiology for Investigating Anesthetic Mechanisms.
2018,
Pubmed
Jenkins,
Evidence for a common binding cavity for three general anesthetics within the GABAA receptor.
2001,
Pubmed
Koska,
Fully automated molecular mechanics based induced fit protein-ligand docking method.
2008,
Pubmed
Lein,
Acute hippocampal slice preparation and hippocampal slice cultures.
2011,
Pubmed
MacIver,
Anesthetic agent-specific effects on synaptic inhibition.
2014,
Pubmed
Mascia,
Ethyl 2-(4-bromophenyl)-1-(2,4-dichlorophenyl)-1H-4-imidazolecarboxylate is a novel positive modulator of GABAA receptors.
2005,
Pubmed
,
Xenbase
Mascia,
Differential modulation of GABA(A) receptor function by aryl pyrazoles.
2014,
Pubmed
,
Xenbase
Naito,
Glycine and GABA(A) ultra-sensitive ethanol receptors as novel tools for alcohol and brain research.
2014,
Pubmed
,
Xenbase
Nguyen,
Behavior and cellular evidence for propofol-induced hypnosis involving brain glycine receptors.
2009,
Pubmed
Pearce,
Physiological evidence for two distinct GABAA responses in rat hippocampus.
1993,
Pubmed
Perkins,
Loop 2 structure in glycine and GABA(A) receptors plays a key role in determining ethanol sensitivity.
2009,
Pubmed
,
Xenbase
Raines,
The pharmacology of etomidate and etomidate derivatives.
2015,
Pubmed
Shanmugasundararaj,
Carboetomidate: an analog of etomidate that interacts weakly with 11β-hydroxylase.
2013,
Pubmed
Vargas-Caballero,
alpha5 Subunit-containing GABA(A) receptors mediate a slowly decaying inhibitory synaptic current in CA1 pyramidal neurons following Schaffer collateral activation.
2010,
Pubmed
Wagner,
Inhibition of adrenal steroidogenesis by the anesthetic etomidate.
1984,
Pubmed
Wang,
An Etomidate Analogue With Less Adrenocortical Suppression, Stable Hemodynamics, and Improved Behavioral Recovery in Rats.
2017,
Pubmed
Waud,
On biological assays involving quantal responses.
1972,
Pubmed
de Wit,
The effect of propofol on haemodynamics: cardiac output, venous return, mean systemic filling pressure, and vascular resistances.
2016,
Pubmed